1. Home
  2. TMQ vs CTXR Comparison

TMQ vs CTXR Comparison

Compare TMQ & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMQ
  • CTXR
  • Stock Information
  • Founded
  • TMQ 2004
  • CTXR 2007
  • Country
  • TMQ Canada
  • CTXR United States
  • Employees
  • TMQ N/A
  • CTXR N/A
  • Industry
  • TMQ Precious Metals
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • TMQ Basic Materials
  • CTXR Health Care
  • Exchange
  • TMQ Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • TMQ 83.6M
  • CTXR 84.9M
  • IPO Year
  • TMQ N/A
  • CTXR N/A
  • Fundamental
  • Price
  • TMQ $0.96
  • CTXR $0.37
  • Analyst Decision
  • TMQ
  • CTXR Strong Buy
  • Analyst Count
  • TMQ 0
  • CTXR 2
  • Target Price
  • TMQ N/A
  • CTXR $5.00
  • AVG Volume (30 Days)
  • TMQ 4.7M
  • CTXR 1.4M
  • Earning Date
  • TMQ 10-08-2024
  • CTXR 12-27-2024
  • Dividend Yield
  • TMQ N/A
  • CTXR N/A
  • EPS Growth
  • TMQ N/A
  • CTXR N/A
  • EPS
  • TMQ N/A
  • CTXR N/A
  • Revenue
  • TMQ N/A
  • CTXR N/A
  • Revenue This Year
  • TMQ N/A
  • CTXR N/A
  • Revenue Next Year
  • TMQ N/A
  • CTXR N/A
  • P/E Ratio
  • TMQ N/A
  • CTXR N/A
  • Revenue Growth
  • TMQ N/A
  • CTXR N/A
  • 52 Week Low
  • TMQ $0.25
  • CTXR $0.25
  • 52 Week High
  • TMQ $1.29
  • CTXR $1.07
  • Technical
  • Relative Strength Index (RSI)
  • TMQ 70.55
  • CTXR 40.18
  • Support Level
  • TMQ $0.91
  • CTXR $0.31
  • Resistance Level
  • TMQ $1.29
  • CTXR $0.51
  • Average True Range (ATR)
  • TMQ 0.11
  • CTXR 0.05
  • MACD
  • TMQ 0.03
  • CTXR 0.01
  • Stochastic Oscillator
  • TMQ 55.80
  • CTXR 11.62

About TMQ Trilogy Metals Inc.

Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-lead-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

Share on Social Networks: